Skip to main content
. Author manuscript; available in PMC: 2023 Jun 28.
Published in final edited form as: Clin Pharmacol Ther. 2020 Jul 18;108(6):1195–1202. doi: 10.1002/cpt.1927

Table 3.

Distribution of F5 p.Arg534Gln genotypes by adjudicated ACEI-AE and ARB-AE status

Group Arg534 only (n) 534Gln carriers (n) Total (n) Association
ACEI-AE/ARB-AE 326 61 387 Odds ratio = 2.85
ACEI/ARB controls 609 37a 646 95% CI, 1.89–4.25
Total 935 98 1,033 P value 1.53 × 10−7

ACEI, angiotensin-converting enzyme inhibitor; AE, adverse event; ARB, angiotensin receptor blocker.

a

One homozygous for 534Gln.